SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,684 | -74.0% | 179 | -40.5% | 0.00% | – |
| Q2 2023 | $14,153 | -12.8% | 301 | -22.2% | 0.00% | – |
| Q1 2023 | $16,239 | +32.6% | 387 | +20.6% | 0.00% | – |
| Q4 2022 | $12,243 | -28.0% | 321 | -24.6% | 0.00% | -100.0% |
| Q3 2022 | $17,000 | +54.5% | 426 | +28.7% | 0.00% | – |
| Q2 2022 | $11,000 | +1000.0% | 331 | +2264.3% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 14 | -48.1% | 0.00% | – |
| Q3 2021 | $1,000 | -80.0% | 27 | -67.9% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 84 | -8.7% | 0.00% | – |
| Q1 2021 | $7,000 | -12.5% | 92 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | -52.9% | 92 | -66.7% | 0.00% | -100.0% |
| Q3 2020 | $17,000 | +112.5% | 276 | +38.0% | 0.00% | – |
| Q2 2020 | $8,000 | +33.3% | 200 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |